CD44 and glioblastoma: In this study, NSC-secreted EVs may possibly provide ready-made factors to GBM cells to block pro-differentiation signals that result in an upregulation of expression of stemness genes CD9 and CD44 along with TUBB3, CD133, and SOX9, leading the cancer cells to shift the transcription to cancer-specific stemness.